EP Patent

EP4342546B1 — Eicosapentaenoic acid ethyl ester for use in reducing the risk of non-fatal stroke in a subject on statin therapy

Assigned to Amarin Pharmaceuticals Ireland Ltd · Expires 2025-06-04 · 1y expired

What this patent protects

Patent listed against Vascepa.

Drugs covered by this patent

Patent Metadata

Patent number
EP4342546B1
Jurisdiction
EP
Classification
—
Expires
2025-06-04
Drug substance claim
No
Drug product claim
No
Assignee
Amarin Pharmaceuticals Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.